Delivery Order SPE2DB22D3501-SPE2DB25FUM13
Award Date
2/7/25
Potential Completion Date
3/3/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,023.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order for the supply of POLIVY 140 MG VIALS, with a completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug POLIVY 140 MG VIALS to the U.S. government. The contract, valued at $20,908.66, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on May 28, 2024, with a completion date of June 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564288200 POLIVY 140 MG VIALS to the U.S. government. The contract, valued at $40,304.38, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,069.09 firm fixed-price delivery order is for the procurement of POLIVY 140 MG VIALS, a pharmaceutical product, with a completion date of February 20, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $10,290.63 firm fixed price order is for the delivery of POLIVY 140 MG VIALS pharmaceutical product, with a completion date of January 11, 2024. The contract has no set-aside designation. AmerisourceBergen Drug Corp has an extensive history of providing pharmaceutical and medical supply...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB25FFE63, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567007103 | POLIVY 140 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $11,023.03, a firm fixed price pricing type, and an ultimate completion date of February 12, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $20,908.66 firm fixed price delivery order is for the supply of 4563344425 POLIVY 140 MG VIALS. The contract has a completion date of February 7, 2024 and was awarded on January 17, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $43,892.31 and covers the delivery of IPOL VIAL 5ML medical products. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,056.20 firm fixed-price delivery order is for the supply of 4566166957 ONIVYDE 43 MG/10 ML VIAL 10ML, with a completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $16,767.44 firm fixed-price delivery order is for the supply of 4566813903 VYVGART 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...